Feature | February 18, 2011

DM Continues on the Fast Track

This article appeared as an introduction to the Digital Mammography Systems comparison chart.

In the 10 or so years since the U.S. Food and Drug Administration (FDA) gave its first approval to a full-field digital mammography (FFDM) system, there have been numerous developments pushing it to the forefront over conventional film systems. In fact, by the end of 2010, the FDA estimated that about 70 percent of mammography units now in use are digital and 70 percent of certified U.S. mammography facilities have at least one digital unit.

While that already may be considered an impressive inroad, thanks to a recent FDA decision to reclassify digital mammography from class III to class II device status, this expansion is likely to continue. Class II devices are considered medium risk and require only 510(k) certification for approval. This is a quicker process than the premarket approval application required for class III, and a few additional vendors are poised to meet that criteria.

Digital mammography received an early boost from results of the Digital Mammographic Imaging Screening Trial (DMIST) in 2005. The study began in October 2001 and enrolled almost 50,000 women with no signs of breast cancer to compare digital and traditional film mammography. It showed there was similar screening accuracy for the overall population of women studied and that digital was significantly better for three categories of women: those under age 50; those of any age with dense breast tissue, and pre- or perimenopausal women of any age.

What’s more, as reported in the February 2010 issue of the American Journal of Roentgenology,1 a subsequent study of data from DMIST showed the radiation dose associated with digital mammography is significantly lower (averaging 22 percent) than conventional film mammography and could be even more for women with dense breasts. In addition, for many facilities, the fact that digital mammography images can be stored and sent electronically is another advantage.

The past 12 months have seen the introduction of a number of digital mammography system enhancements and related products, although not all are available in the United States yet.

Among them:

• GE Healthcare showed its SenoBright contrast enhanced spectral mammography (CESM) technology at RSNA, as an upgrade to its Senographe DS and Senographe Essential DM equipment. CESM is designed to let a physician image blood flow through angiography of the breast using a contrast agent and a dual energy acquisition technique. This can highlight angiogenesis, the growth of small blood vessels potentially related to the presence of cancer. SenoBright has not received the CE mark and is not available for sale in the United States.

• Also at RSNA, Planmed showed its Nuance Excel FFDM system, which is pending FDA clearance. It features an amorphous selenium direct-conversion detector, 24 by 41 cm size, tungsten tube, Ag/Rh filters and Flex-AEC automated exposure control.

• Hologic introduced Atrix Medical Systems QC-Track quality control software as an enhancement for its Selenia Dimensions 2-D FFDM system in mid-2010. This data capture and graphical reporting software and hardware solution automates the tracking and graphing required by the Mammography Quality Standards Act for many devices associated with breast imaging facilities.

Late last year, Hologic announced it had received an “approvable letter” for the Selenia Dimensions system for breast tomosynthesis (3-D) imaging, which was launched in Europe in 2008. The letter was issued by the FDA’s Center for Devices and Radiological Health.

• Philips made an introduction at RSNA of an advanced stereotactic option for its MammoDiagnost DR. The system, which is not available in North America, includes unique image processing to help clinicians identify tiny microcalcifications and view breast tissue structures.

• In November, the FDA cleared the Volpara breast imaging software for digital mammography systems. It automatically computes volumetric breast tissue density from screening mammograms. It initially was available for Hologic and GE Healthcare systems, with other systems undergoing validation.

References:
1 Am. J. Roentgenol., Feb. 2010; 194: 362-369.

 

Related Content

FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model.

A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D.

Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis
Three-dimensional (3-D) printing and...
The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

Sponsored Content | Case Study | Ultrasound Imaging | July 01, 2019
“With our present technology, we often struggle with large patients,” said Richard G.
David Anderson at SIIM

David Anderson presents information about the development of artificial Intelligence (AI) at SIIM 2019 as his father, Charles, looks on from a front row seat. The father-son team presented information at the SIIM annual meeting about their use of relatively shallow Deep Learning networks to analyze chest radiographs with AI.

Feature | Information Technology | July 01, 2019 | By Greg Freiherr
Two simple neural networks are better than one complex one, according to a father-son team of entrepreneurs.